It does. So I would assume that the Company has paid for the manufacturing runs with the funds already at hand?
So why the urgency for a cap raise last week? As @Steini and I have been suggesting - they could easily have announced the results for the CDH-17 and CORE-NK updates and see where the share price went. The VWAP would have been higher allowing for a higher raise price and therefore less dilution.
And it would also be interesting to see how many oppies would be exercised with them being in the money.
Perhaps Hopper and his family could start the ball rolling?
- Forums
- ASX - By Stock
- CHM
- Ann: CHM CDH17 ADVANCES TO DOSE LEVEL 2
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

Ann: CHM CDH17 ADVANCES TO DOSE LEVEL 2, page-29
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $2.148K | 537.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4926903 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 17489088 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 4926903 | 0.004 |
40 | 26959271 | 0.003 |
16 | 15400505 | 0.002 |
11 | 53600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 17489088 | 18 |
0.006 | 13134684 | 14 |
0.007 | 3100000 | 2 |
0.008 | 8685291 | 7 |
0.009 | 2390797 | 5 |
Last trade - 11.52am 30/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |